Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Orphan Drugs
  • R&D 100 Awards

Sphere Fluidics, Peak Analysis and Automation partner to streamline single cell analysis

By Chris Newmarker | November 6, 2019

Sphere Fluidics PAA Peak Analysis and AutomationSphere Fluidics (Cambridge, U.K.) and Peak Analysis and Automation (Farnborough, U.K.) have launched a new product as they seek to further streamline single-cell analysis in biopharmaceutical workflows.

The companies yesterday announced they have integrated Sphere Fluidics’ Cyto-Mine single-cell analysis system with PAA’s automated plate handler, S-LAB.

Automated micro-plate handling minimizes hands-on involvement and saves time in antibody discovery and cell line development, according to Sphere Fluidics and PAA. Said the companies: “By replacing manual barcode scanning of multi-well microtiter plates and plate loading in the final picodroplet dispensing phase of the Cyto-Mine, the integration of S-LAB increases user flexibility, overall throughput and efficiency.”

The integrated system combines single-cell screening, sorting, imaging, isolation and clone verification. It’s able to process up to 40 million heterogenous mammalian cells in a few hours, according to the companies. The small footprint of the system enables its use in a cell culture hood, which, combined with the de-lidding capability of S-LAB, ensures that processed cells remain sterile.

Sphere Fluidics and PAA first announced their collaboration in January 2019.

Tell Us What You Think! Cancel reply

Related Articles Read More >

Johnson & Johnson Merck COVID-19 vaccine
Report: Biden to announce partnership for Merck to make J&J’s COVID-19 vaccine
Johnson & Johnson
8 things to keep in mind related to the FDA advisory meeting on J&J vaccine
master mixes
Air-dryable master mixes replace lyophilization in the manufacturing of molecular assays
COVID-19 therapies vaccines coronavirus
Could a third vaccine shot better protect against COVID-19 variants?

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup

R&D Twitter

Tweets by @RandDWorld
Drug Discovery and Development
  • Enews Signup
  • Contact Us
  • R&D World
  • Pharmaceutical Processing
  • Drug Delivery Business News

Copyright © 2021 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Orphan Drugs
  • R&D 100 Awards